​

Translational Development Acquisition Stock (NASDAQ:TDAC)

RevenueOwnershipFinancialsChart

Previous Close

$10.70

52W Range

$10.29 - $10.80

50D Avg

$10.69

200D Avg

$10.54

Market Cap

$263.54M

Avg Vol (3M)

$104.45K

Beta

0.02

Div Yield

-

TDAC Company Profile

Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Feb 20, 2025

Website

TDAC Performance

TDAC Financial Summary

Dec 24Dec 23Dec 22
Revenue---
Operating Income$-196.36K$-485.55K$-70.66K
Net Income$-71.01K$-485.55K$-70.66K
EBITDA$-71.01K$-485.55K-
Basic EPS$-0.21$-0.12$-0.02
Diluted EPS$-0.21$-0.12$-0.02

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
SZZLSizzle Acquisition Corp. II
FACTFACT II Acquisition Corp
HCMAHCM Acquisition Corp
MACIMelar Acquisition Corp. I